Valuation: Terumo Corporation

Market Cap 3,500B 22.2B 19.2B 17.93B 16.45B 30.94B 2,112B 31.43B 210B 82.57B 1,059B 83.35B 81.53B P/E 2027 *
18.9x
P/E 2028 * 18.5x
Enterprise Value 3,566B 22.61B 19.56B 18.27B 16.76B 31.52B 2,152B 32.02B 214B 84.11B 1,079B 84.91B 83.05B EV / Sales 2027 *
2.85x
EV / Sales 2028 * 2.58x
Free-Float
97.07%
Yield 2027 *
1.55%
Yield 2028 * 1.7%
1 day+8.53%
1 week+11.42%
Current month+10.82%
1 month+17.66%
3 months+31.60%
6 months+21.95%
Current year+13.46%
1 week 2,280
Extreme 2280
2,579.5
1 month 2,133
Extreme 2133
2,579.5
Current year 1,900
Extreme 1900
2,579.5
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 75 25/06/2020
Director/Board Member 63 21/06/2019
Chairman 68 01/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+8.53%+11.42%-5.54%+18.17% 22.2B
-0.14%+2.00%-19.71%+2.38% 187B
+1.44%+2.07%-6.16%+5.09% 112B
-1.40%+2.93%+12.39%+72.56% 61.15B
+2.38%+3.92%+32.78%+60.21% 54.39B
-0.12%+6.79%-8.60%-37.18% 48.17B
+2.08%+1.56%+7.47%-23.62% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+46.93%-11.52% 24.92B
+2.45%+3.97%-2.22%+4.63% 23.15B
Average +1.64%+1.89%+6.37%+10.08% 59.5B
Weighted average by Cap. +0.44%+2.17%-1.78%+11.35%

Financials

2027 *2028 *
Net sales 1,251B 7.93B 6.86B 6.41B 5.88B 11.06B 755B 11.23B 75.19B 29.51B 378B 29.79B 29.14B 1,331B 8.44B 7.3B 6.82B 6.26B 11.77B 803B 11.95B 80B 31.4B 403B 31.7B 31.01B
Net income 183B 1.16B 1B 936M 859M 1.62B 110B 1.64B 10.98B 4.31B 55.28B 4.35B 4.26B 190B 1.2B 1.04B 971M 890M 1.67B 114B 1.7B 11.39B 4.47B 57.32B 4.51B 4.41B
Net Debt 65.54B 416M 360M 336M 308M 579M 39.56B 588M 3.94B 1.55B 19.83B 1.56B 1.53B -62.96B -399M -345M -323M -296M -556M -38B -565M -3.78B -1.49B -19.05B -1.5B -1.47B
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
10/08/26 ¥2,575.50 +8.53% 8,398,500
07/08/26 ¥2,373.00 +2.64% 4,340,100
06/08/26 ¥2,312.00 +1.05% 4,737,000
05/08/26 ¥2,288.00 -1.51% 4,036,400
04/08/26 ¥2,323.00 +0.50% 2,875,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,373.00JPY
Average target price
3,075.38JPY
Spread / Average Target
+29.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock